hiccups on semaglutide Ozempic (Semaglutide): GLP-1 receptor agonist used for type 2 diabetes. It commonly causes dose-related gastrointestinal side-effects, while important serious warnings include pancreatitis, gallbladder disease, dehydration-related acute kidney injury With Even More Powerful GLP-1s

13 Subcutaneous Injection Technique (Patient Education)How to administer a subcutaneous injection: clinical technique guidelines

Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2026

The same principles that guide peptide dosing strategies across multiple compounds apply here: start low, increase slowly, and pay attention to response rather than rushing to an arbitrary target dose

SURMOUNT-5: The First Direct Head-to-Head Trial For years, comparing tirzepatide weight loss results to semaglutide weight loss results required inferring from separate trials run in different patient groups

doi: 10.1111/dom.13955 113 FalkE